Evidence map›Paper›PMID 39396893›Full record

ArticleBrain & development2024

Characterizing visual processing deficits in cerebral adrenoleukodystrophy.

Camille S Corre, Melissa Bambery, Christopher R Bennett, Amanda Nagy, Claire E Manley, Ellen Winter, Cary Peregoy, Daniel Kelly, Haley Andonian, Stacy Maciel and 3 more

Abstract read
In one paragraph

Article in Brain & development, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Camille S CorreDepartment of Neurology, University of Rochester Medical Center, United States; Department of Neurology, Massachusetts General Hospital, United States.
Melissa BamberyDepartment of Neurology, Massachusetts General Hospital, United States.
Christopher R BennettThe Laboratory for Visual Neuroplasticity, Massachusetts Eye and Ear, United States.
Amanda NagyDepartment of Neurology, Massachusetts General Hospital, United States; Harvard Medical School, United States.
Claire E ManleyDepartment of Neurology, Massachusetts General Hospital, United States.
Ellen WinterDepartment of Neurology, Massachusetts General Hospital, United States.
Cary PeregoyDepartment of Neurology, Massachusetts General Hospital, United States.
Daniel KellyDepartment of Neurology, Massachusetts General Hospital, United States.
Haley AndonianDepartment of Neurology, Massachusetts General Hospital, United States.
Stacy MacielDepartment of Neurology, Massachusetts General Hospital, United States.
Catherine BeckerDepartment of Neurology, Massachusetts General Hospital, United States.
Lotfi B MerabetThe Laboratory for Visual Neuroplasticity, Massachusetts Eye and Ear, United States; Harvard Medical School, United States.
Florian S EichlerDepartment of Neurology, Massachusetts General Hospital, United States; Harvard Medical School, United States. Electronic address: feichler@mgb.org.

Funding

Validation of the GMFC-MLDU54NS115052 · NINDS · CHILDREN'S HOSP OF PHILADELPHIA · PI Laura Ann Adang, FLORIAN S EICHLER · 2019 to 2026
$14.3M
NINDS NIH HHS U54 NS115052
6 · The paper itself

Abstract

BACKGROUND AND

objectivesCerebral adrenoleukodystrophy (CALD) can cause visual impairment, but early symptoms are often missed or misdiagnosed. The framework of cerebral visual impairment (CVI) distinguishes deficits in sensory detection ("lower order") from those of perception and interpretation ("higher order"). This study describes visual deficits in patients with CALD and higher order visual function assessed with a virtual reality (VR) interface combined with eye tracking.

methodsA retrospective medical record review assessed the prevalence of visual deficits in patients with CALD, as well as lesion burden on brain MRI using the Loes MRI severity score. A VR-based task measured visual spatial processing performance in participants with CALD and controls.

resultsOut of 89 CALD patients, 69 % had at least one sign or symptom of visual impairment. Lower order deficits were seen in 56 % of patients, and higher order deficits were seen in 59 % of patients who underwent neuropsychological testing. Even in early stage disease (Loes MRI severity score ≤ 3), visual impairment was present in more than half of patients (58 %). On prospective VR-based assessment, the CALD group (n = 30) had impaired visual search performance (lower success rate and longer reaction time) compared with controls (n = 38). In both groups, there was a trend of worsening performance with increasing task difficulty. DISCUSSION: Higher order visual deficits, not just impairment of visual acuity, visual fields, or oculomotor function, are common in all stages of CALD. Beyond neuropsychological testing, VR-based functional testing allows for quantitative assessment of higher order visual perceptual deficits that are relevant to everyday tasks and may serve as an important marker of neurological decline.

Indexed as

AdrenoleukodystrophyMagnetic Resonance ImagingVision DisordersVisual PerceptionAdolescentAdultBrainChildFemaleHumansMaleMiddle AgedNeuropsychological TestsRetrospective StudiesVirtual RealityYoung AdultAdrenoleukodystrophyCerebral visual impairmentVirtual realityVisual processing

Identifiers

PMID39396893
PMCPMC11841130

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.